Where is Shionogi located?

Shionogi is headquartered in Florham Park, United States. It is registered at Florham Park, New Jersey.

How many employees does Shionogi have?

As of Sep 30, 2026, the latest employee count at Shionogi is 721.

Where does Shionogi rank among its competitors?

Shionogi ranks 41st amongst 1239 active competitors, of which 43 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Laboratorio Reig Jofre, which secured $14.7M in May, 2025.

Who are the top competitors of Shionogi?

Shionogi's top competitors include Bayer, Teva Pharmaceuticals and Wockhardt. Among them, Laboratorio Reig Jofre secured the most recent funding round in May, 2025.

Shionogi - 2026 Company Profile, Funding & Competitors

Shionogi is a public company based in Florham Park (United States), founded in 1878. It operates as a Developer and manufacturer of pharmaceuticals for a range of diseases. The company has 1239 active competitors, including 43 funded and 337 that have exited. Its top competitors include companies like Bayer, Teva Pharmaceuticals and Wockhardt.

Company Details

Shionogi is engaged in developing and marketing a range of pharmaceutical and health maintenance products. Product categories include women's health, pain, anti-infectives, cardiovascular, pediatrics, and others. Products include Osphena (FDA approved for moderate to severe painful sex after menopause), Xodol (Pain), Doribax (Anti-Infective), Fortamet (Hyperglycemia), Solar (Blood Pressure) and Methylin (CNS stimulant). The company also claims to have a pipeline of drugs for the treatment of infection, pain, women's health, rhinitis, cancer, and HIV. In 2022, the company recorded annual revenues of $3.45B and a net profit of $1.53B.

Website: www.shionogi.com/us/en/
Registered Address: Florham Park, New Jersey

Key Metrics

Founded Year

1878

Location

Florham Park, United States

Stage

Public

Investors

NovaQuest Capital Management

Ranked

41^st among 1239 active competitors

Employee Count

721 as on Sep 30, 2026

Investment & Acquisitions

IntraBio & 15 more

Similar Companies

Teva Pharmaceuticals & 1463 more

Exit Details

Public

View Shionogi's full profile

Shionogi is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
SHIONOGI, INC. CIN: 320272653 , United States, Active	Dec 26, 999	-	333 (As on Dec 31, 2024)	-

Shionogi got listed on May 16, 1949.

Click here to take a look at Shionogi's IPO in detail

Shionogi is a funded company. Shionogi has 1 institutional investor.

View details of Shionogi's funding rounds and investors

Shionogi's employee count trend

Shionogi has 721 employees as of Sep 26. Here is Shionogi's employee count trend over the years:

Uncover Shionogi's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Shionogi include Bayer, Teva Pharmaceuticals and Wockhardt. Here is the list of Top 10 competitors of Shionogi, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Bayer 1863, Leverkusen (Germany), Public	Manufacturer of drugs	-	Digital Pharma Lab, B Capital Fund & 9 others	76/100
2nd	Teva Pharmaceuticals 1901, Petah Tikva (Israel), Public	Traditional company engaged in manufacturing generics	$500M	Berkshire Hathaway, JANA Partners & 3 others	75/100
3rd	Wockhardt 1967, Mumbai (India), Public	Manufacturer of pharmaceuticals, biotechnology products, and active pharmaceutical ingredients	-	HDFC Mutual Fund, Tata Mutual Fund & 12 others	71/100
4th	Biological E 1953, Hyderabad (India), Funding Raised	Developer of vaccines for treating multiple diseases	-	Gates, IFC & 3 others	69/100
5th	Cipla 1935, Mumbai (India), Public	Manufacturer of APIs, generic drugs, and formulation development services	-	MUFG, Eight Roads Ventures & 3 others	69/100
6th	The Alvogen 2009, Morristown (United States), Acquired	Developer and marketer of pharmaceutical products	$156M	Morgan Stanley, IMM Private Equity & 11 others	69/100
7th	Emcure 1981, Pune (India), Public	Developer, manufacturer, and markets a broad range of pharmaceutical products	$50M	Blackstone, Bain Capital	68/100
8th	Amneal 2002, Bridgewater (United States), Public	Manufacturer of generics formulations	-	Tarsadia, GE Capital & 2 others	68/100
9th	Laboratorio Reig Jofre 2000, Barcelona (Spain), Public	Manufacturer of pharmaceutical products and food supplements	-	CDTI, Europa	68/100
10th	Strides Pharma Science 1990, Bengaluru (India), Public	Manufacturer of generic pharmaceutical products and various specialty medical formulations	-	InvAscent, Oman India Joint Investment Fund ... & 2 others	68/100
41st	Shionogi 1878, Florham Park (United States), Public	Developer and manufacturer of pharmaceuticals for a range of diseases	-	NovaQuest Capital Management	59/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Shionogi's competitors? Click here to see the top ones

Shionogi has made 13 investments in companies including Celaid Therapeutics and Dioseve Inc. Shionogi has also acquired 3 companies including IntraBio and Qpex Biopharma.

Here is the list of investments & acquisitions:

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Oct 05, 2026	Acquisition	IntraBio	2015	Austin (United States)
Oct 04, 2026	Investments	Celaid Therapeutics	2020	Bunkyo (Japan)
Jun 12, 2026	Investments	Dioseve Inc	2021	Bunkyo (Japan)